ILCF Grant Recipient Spotlights

Funding the next generation of lung cancer luminaries.

Featured Spotlight

Biagio Ricciuti, MD

Staff Scientist II - MD at Dana-Farber Cancer Institute

With the support of the ILCF, we have demonstrated that genomically defined subset of lung cancers
harboring mutations in genes involved in DNA damage repair (DDR) derive improved clinical outcomes
with PD-(L)1 blockade.

Wencai Zhang, MD

With the support, I can utilize cutting-edge metabolomic and whole transcriptomic approaches to advance our understanding of the interaction of metabolite-miRNA in driving tumor initiation.

Read Spotlight

Grant Recipient

Hua Zhang, MD

"My career goal is leading a multidisciplinary research laboratory focused on addressing challenges in the treatment of lung cancer."

Read Spotlight

Grant Recipient

Alice Berger, MD

"Ultimately my goal is to provide new therapeutic options for patients with lung cancer."

Read Spotlight

Grant Recipient

Aaron C. Tan, MD

"I hope my future research can build on this foundation, to drive innovation, generate novel data, and ultimately improve outcomes for patients."

Read Spotlight

Support Researchers!

People who are diagnosed with lung cancer gain hope through improved treatment options resulting from scientific advances. The International Lung Cancer Foundation exists to fund innovative research that leads to scientific advances in the detection and treatment of lung cancer and other thoracic malignancies. We need your help to fund our next round of researchers and their innovative projects. Despite being the leading cause of cancer death, lung cancer receives far less government research funding than any other cancer, so research support from corporations, foundations, and individual donors is crucial.

Fund Research Now